✦ LIBER ✦

Multicenter Randomized, Double-blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris

✍ Scribed by Werth, V. P.; Fivenson, D.; Pandya, A. G.; Chen, D.; Rico, M. J.; Albrecht, J.; Jacobus, D.

Book ID: 115511834
Publisher: American Medical Association
Year: 2008
Tongue: English
Weight: 136 KB
Volume: 144
Category: Article
ISSN: 0003-987X
DOI: 10.1001/archderm.144.1.25

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The antimicrobial effect of Iseganan HCl

The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial

✍ Sharon Elad; Joel B. Epstein; Judith Raber-Durlacher; Peter Donnelly; Jacob Stra 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

Efficacy of vitamin D3 as add-on therapy

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

✍ Joost Smolders; Raymond Hupperts; Frederik Barkhof; Luigi M.E. Grimaldi; Trygve 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 355 KB

O-047 International multicenter randomiz

O-047 International multicenter randomized double-blind placebo-controlled phase 3 clinical trial of INS316 as an adjunct for acquiring deep-lung sputum specimens for the cytological diagnosis of lung cancer

✍ Johnson, F.; Yung, R.; Sussman, R.; Kellerman, D.; Durham, T.; Gorden, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Febuxostat, a novel nonpurine selective

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty-eight–day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

✍ Michael A. Becker; H. Ralph Schumacher Jr.; Robert L. Wortmann; Patricia A. MacD 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective Gout affects ∼1–2% of the American population. Current options for treating hyperuricemia in chronic gout are limited. The purpose of this study was to assess the safety and efficacy of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in establishing normal

Long-term safety and maintenance of clin

Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double-blind, placebo-controlled trial

✍ George Nuki; Barry Bresnihan; Moraye B. Bear; Dorothy McCabe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 3 views

A phase II, multicenter, randomized, dou

A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)

✍ E. Anaissie; M.W. Schuster; D. Hurd; W. Bensinger; J. Mason; J.M. McCarty; R. Ri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB